IMPORTANT INFORMATION FOR PRIVATE INVESTORS

Our investments place your capital at risk. We do not provide investment, tax or legal advice and we recommend you seek professional advice if you are considering investing with us. You may lose part or all of the amount you invest with us. We invest in unquoted shares in small companies. The value of these shares can be volatile, and the shares are often difficult to sell. The tax reliefs associated with our investments depend on the individual circumstances of each investor and may be subject to change. Past performance is not a reliable indicator of future results. Our forecasts and performance targets cannot accurately predict how investments will perform.

ACCEPT DECLINE
Change Visitor Type Sign up to our newsletter

NEWS & VIEWS

Oxford Capital and our portfolio companies

Oxford Capital features in Intelligent Partnership’s quarterly EIS update

By Oxford Capital | October 12, 2021
Oxford Capital has sponsored the latest quarterly EIS update from Intelligent Partnership – the guide is packed full of information on the current state of the market and the outlook for early stage companies.  It also includes an overview of the Oxford Capital Growth EIS strategy.  Worth a read!  
Read More

Oxford Capital named one of the most active seed VCs in the UK

By Oxford Capital | October 6, 2021
We were thrilled to be named one of the most active seed VCs in the UK by the UK Business Angels Association – our portfolio companies have shown a huge amount of resilience and growth over the last 18 months and there’s so much to be excited about within the UK early stage tech sector.
Read More

A VC’s period of maximum influence

By Oxford Capital | September 28, 2021
Mark Bower-Easton, Business Development Manager, Oxford Capital When an entrepreneur launches a new business, two things are essential – a good idea, and enough capital to bring that idea to fruition. In the initial stages, most of the money will come from their own savings, family members and friends. However, they will arrive at a…
Read More

Boehringer Ingelheim and Oxford BioTherapeutics Partnership Advances Second Oncology Drug Candidate into the Clinic

By Oxford Capital | September 20, 2021
Positive news from portfolio company Oxford BioTherapeutics – it has announced today that it has achieved another milestone with Boehringer Ingelheim for the progress of a second oncology drug candidate.
Read More

Oxford Capital appoints Stephen Hampson as Investment Director

By Oxford Capital | September 20, 2021
Oxford Capital appoints Stephen Hampson as Investment Director  – Hampson has over 20 years of experience in building technology companies as both a CEO and investor – Created more than 30 deep-tech companies as founder and CEO of Powerhouse – Joins the investment team to manage the ventures strategy – focusing on early stage UK…
Read More

IFA magazine interview – Building mental resilience

By Oxford Capital | September 15, 2021
We’ve continued our conversations with IFA Magazine on the importance of building the mental resilience of our founders and guiding them through the ups and downs of building their businesses. A topic that may also resonate with advisers.  Read more in this month’s digital magazine (pages 42-43)
Read More

Portfolio company, Red Sift announces expansion into Australia

By Oxford Capital | August 26, 2021
Cyber security specialist, Red Sift has announced it is expanding into the Australian market and has opened an office in Sydney.
Read More

Outplay Entertainment appoints Stefan Lampinen as new independent board member

By Oxford Capital | August 25, 2021
Great news for portfolio company Outplay Entertainment Ltd – it has appointed industry heavywight Stefan Lampinen as a new independent board member. Stefan brings decades of video games industry experience, expertise and strategic insight to the Outplay board.
Read More

EIS Tax Reliefs focus – Inheritance Tax Relief

By Mark Bower-Easton, Business Development Manager | August 19, 2021
Mark Bower-Easton, Business Development Manager, Oxford Capital The government has been promoting private investment in to early-stage businesses via the Enterprise Investment Scheme (EIS) since 1994, and it shouldn’t be underestimated just how important entrepreneurial businesses are to the UK economy. EIS are high risk, but also offer the potential of strong returns, along with…
Read More

Growth Investor Awards 2021 finalist – Best Investment Platform

By Oxford Capital | August 18, 2021
We’re thrilled to be shortlisted in this year’s Growth Investor Awards for Best Investment Platform for our Co-Investor Circle. Looking forward to the awards in November!
Read More

Awards

  • BEST EIS
    FUND MANAGER    2013,2012,2010 AND 2006

  • VENTURE CAPITAL
    HOUSE OF THE YEAR    WINNER 2013 AND 2005

  • MOST IMPACTFUL
    INVESTMENT    WINNER 2017

  • BEST ANGEL
    SYNDICATE    WINNER 2018

  • BVCA Excellence in ESG
    GP CATEGORY    COMMENDED 2020

  • VC INVESTOR OF THE YEAR
    GIANT HEALTH AWARDS    WINNER 2020

  • EXIT OF THE YEAR
    ONE TO WATCH    2020

  •            

    EXIT OF THE YEAR 2021 (FINALIST)UK BAA AWARDS